CiteAb - Data Accelerating Science Data Accelerating Science
Menu
  • Reagent Search
    • Antibodies
      Recombinant, monoclonal & polyclonal antibodies and primary & secondary antibodies.
    • Biochemicals
      Carbohydrates, peptides, bioactive small molecules, buffers, dyes and lipids.
    • Cell Lines & Models
      Cell lines, tissues, bacteria & viruses, and animal models.
    • Kits & Assays
      ELISAs, multiplex immunoassay kits, detection/staining kits and conjugation/labelling kits.
    • Instruments
      Microscopes, flow cytometers, spectrometers, and other laboratory instruments.
    • Nucleotides
      Plasmids, primers, RNA, siRNA, shRNA, gRNA, viral vectors and particles.
    • Proteins
      Enzymes, growth factors, binding proteins (e.g. streptavidin) and protein mixtures (e.g. bovine serum).
  • Image Search
  • Custom Suppliers
    • Antibody Suppliers
      Polyclonal, monoclonal, recombinant or alternative affinity reagent production.
    • Cell line Suppliers
      Knockout cell lines, knockin cell lines, gene activation & repression and reporter cell lines.
    • Histology Suppliers
      Immunohistochemistry (IHC), in situ hybridisation (ISH), tissue microarray staining (TMA), and more.
    • Peptides Suppliers
      Standard and modified sequences, fluorescent, isotope and radioactive labelled peptides, and more.
    • Sequencing Suppliers
      Whole Genome Sequencing, Antibody Sequencing, Targeted Sequencing, and more.
  • Supplier Partnerships
  • Data Services
    • Reagent Suppliers
      Powerful life science market data, accurate product citations & published images and listing on our popular reagent search engine.
    • Pharma, Biotech & Academic Research Institutions
      Accelerate preclinical research by licensing our comprehensive life science reagent database for totally flexible and private use.
    • Investment, Research & Advisory Companies
      Power unique and quantitative analysis into life science reagent and equipment manufacturer performance to help you make more informed investment decisions.
    • Scientific Publishers
      Partner with CiteAb to maximise exposure, researcher benefit and revenue from your publications.
  • Sign in or Register
Sign in or Register

CD55 limits sensitivity to complement-dependent cytolysis triggered by heterologous expression of α-gal xenoantigen in colon tumor cells.

Abstract

Engineering cancer cells to express heterologous antigen α-gal and induce the destruction of tumor cells depending on the complement cascade may be a promising strategy of tumor therapy. However, the feasibility and effect of using α-gal to induce colorectal adenocarcinoma cell line cytolysis is not yet known. In this study, we evaluated α-gal expression's ability to sensitize human colorectal adenocarcinoma cell lines to complement attack in cell lines LoVo, SW620, and Ls-174T. Nearly all α-gal-expressing LoVo and SW620 cells were killed by normal human serum (NHS), but α-gal-expressing Ls-174T cells showed no significant lysis. We analyzed the expression levels of membrane-bound complement regulatory proteins (mCRPs) on the three cell lines, and their protective role in α-gal-mediated activation of the complement. LoVo showed no expression of any of the three proteins. CD59 was strongly expressed by SW620 and Ls-174T. CD46 and CD55 varied between the two cell lines. CD46 on SW620 was only half the intensity of CD46 on Ls-174T. Ls-174T showed a notable expression of CD55, while expression of CD55 on SW620 was not detected. The sensitivity of Ls-174T expressing α-gal to NHS greatly increased following the downregulation of CD46 and CD55 with short hairpin RNA (shRNA). However, there is no increase in cell killing when CD59 expression was diminished. Our findings suggest that the use of α-gal as antigen to induce tumor cell killing may be a potential therapeutic strategy in colon cancer and that CD55 plays a primary role in conferring resistance to lysis.Copyright © 2014 the American Physiological Society.

Authors

Yanxia Wu, Yaogeng Wang, Feng Qin, Zhu Wang, Yu Wang, Yajun Yang, Hong Zheng, Yanping Wang

Laboratory of Molecular Diagnosis of Cancer, West China Hospital, Sichuan University, Chengdu, China; State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China;

Article Galaxy PDF

Loading published images for this product

4 products referenced in this paper

(sc-52647) CD46 Antibody (M177)

an Antibody by Santa Cruz Biotechnology

(sc-59092) CD55 Antibody (BRIC 216)

an Antibody by Santa Cruz Biotechnology

(sc-59095) CD59 Antibody (YTH53.1)

an Antibody by Santa Cruz Biotechnology

1 more citation
Register a CiteAb account today to view them.
Sign in or Register now

Journal American Journal of Physiology - Gastrointestinal and Liver Physiology

Volume 306

Issue 12

Pages G1056-64

Publication Date 15 June 2014

View on PubMed®

Publication metadata is provided by PubMed®, courtesy of the U.S. National Library of Medicine. Information for this publication was last updated on 2026-08-26 19:14:06 UTC.

Join thousands of people who already enjoy the CiteAb newsletter

Stay up to date with improvements to the CiteAb Explore Platform and data services, news of our partnerships, product launches and the CiteAb Awards, and get our latest market data analysis straight to your inbox.

Sign up
×

We just need a few more details to better tailor our newsletter to you:

CiteAb Explore Platform
  • Image search engine
  • Antibody search engine
  • Biochemical search engine
  • Cell Lines & Models search engine
  • Kits & Assays search engine
  • Instruments search engine
  • Nucleotide search engine
  • Protein search engine
  • Custom suppliers
  • Request a Demo
Research Resources
  • Antibody dilution calculator
  • Molarity calculator
  • Finding the right antibody
  • Citing an antibody
Data Licensing
  • Pharma/Biotech
  • Finance
  • Publishers
  • Integrations
Market Data
  • Antibody market data
  • Biochemical market data
  • Cell Lines & Models market data
  • Instrument market data
  • Kits & Assay market data
  • Protein market data
Supplier Partnerships
  • Citation & Image Provision
  • Listing on CiteAb
  • Market Data
  • Case Studies
CiteAb Information
  • Our story
  • Blog
  • Contact
  • Careers
  • CiteAb publications
  • CiteAb awards
  • Facebook
  • LinkedIn
  • Instagram
The world's largest antibody search engine, with results ranked by citations.

Data Accelerating Science

CiteAb helps researchers find reliable reagents through the Explore Platform, combining powerful reagent and image search tools. We also license our world-class data to pharma & biotech companies, investors and sci-tech companies, and partner with leading life science suppliers.

Publication metadata is provided by PubMed®, a database of the US National Library of Medicine. PubMed® is a registered trademark of US National Library of Medicine.

Company registered in England #08530854. VAT #179706954.
Copyright © CiteAb Ltd 2026. All rights reserved.

  • Privacy policy
  • Cookie policy
  • Terms of use
  • Subscription Terms and Conditions

In partnership with:

  • Storm Consultancy
  • University of Bath
Proud recipient of the Queen's Award for Innovation 2022